Literature DB >> 11592848

Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex.

S Akbarian1, R Z Chen, J Gribnau, T P Rasmussen, H Fong, R Jaenisch, E G Jones.   

Abstract

Dysfunction of the prefrontal cortex may contribute to the autistic features and mental retardation of Rett syndrome, a neuropsychiatric condition caused by mutations of the gene encoding methyl-CpG-binding protein 2 (MeCP2). Because nothing is known about the expression of MeCP2 and other chromatin-associated factors in primate brain, we studied in monkey prefrontal cortex and murine cerebral cortex expression patterns of MeCP2 and of macrohistone H2A (MacroH2A), which like MeCP2 is associated with transcriptionally silent chromatin. In both species, MeCP2 and MacroH2A appeared to be ubiquitously expressed by cortical neurons, including projection neurons and GABAergic interneurons. In the adult monkey, MeCP2 expression was robust throughout all layers of the prefrontal cortex but it was limited in fetal monkeys at embryonic day 110 to the deeper cortical layers and the subplate. These results suggest that MeCP2 may be important for neuronal maintenance in the developing and in the mature primate prefrontal cortex, consistent with the previously reported phenotype of MeCP2-null mutant mice. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592848     DOI: 10.1006/nbdi.2001.0420

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  52 in total

Review 1.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

2.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

Review 3.  Histone variants in metazoan development.

Authors:  Laura A Banaszynski; C David Allis; Peter W Lewis
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

4.  Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.

Authors:  E Dong; R C Agis-Balboa; M V Simonini; D R Grayson; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

Review 5.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

6.  macroH2A1 histone variants are depleted on active genes but concentrated on the inactive X chromosome.

Authors:  Lakshmi N Changolkar; John R Pehrson
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

7.  Mechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null Mice.

Authors:  Michael P Sceniak; Min Lang; Addison C Enomoto; C James Howell; Douglas J Hermes; David M Katz
Journal:  Cereb Cortex       Date:  2015-02-07       Impact factor: 5.357

8.  Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.

Authors:  Christopher A Chapleau; Gaston D Calfa; Meredith C Lane; Asher J Albertson; Jennifer L Larimore; Shinichi Kudo; Dawna L Armstrong; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-05-12       Impact factor: 5.996

9.  Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia.

Authors:  J C Russell; M E Blue; M V Johnston; S Naidu; M A Hossain
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

10.  Ethanol-induced epigenetic regulations at the Bdnf gene in C57BL/6J mice.

Authors:  E Stragier; R Massart; M Salery; M Hamon; D Geny; V Martin; F Boulle; L Lanfumey
Journal:  Mol Psychiatry       Date:  2014-04-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.